Naser Hadavand

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis Research · 2020 · 84 citations · Full text

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis and Haemostasis · 2021 · 78 citations · Full text

Role of pharmacist counseling in pharmacotherapy quality improvement

Mohammadreza Javadi, Yalda Sanii, Hassan Torkamandi et al. · Journal of Research in Pharmacy Practice · 2016 · 75 citations · Full text

A 3-Armed Randomized Controlled Trial of Nurses’ Continuing Education Meetings on Adverse Drug Reactions

Amir Sarayani, Fahimeh Naderi-Behdani, Naser Hadavand et al. · Journal of Continuing Education in the Health Professions · 2015 · 14 citations

Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS

Pooneh Salari, M Mojtahedzadeh, Atabak Najafi et al. · Journal of Clinical Pharmacy and Therapeutics · 2005 · 13 citations